A
Price
$134.58
Change
-$0.96 (-0.71%)
Updated
Dec 30, 01:27 PM (EDT)
57 days until earnings call
AZTA
Price
$51.30
Change
-$0.27 (-0.52%)
Updated
Dec 27 closing price
43 days until earnings call
Ad is loading...

A vs AZTA

Header iconA vs AZTA Comparison
Open Charts A vs AZTABanner chart's image
Agilent Technologies
Price$134.58
Change-$0.96 (-0.71%)
Volume$500
CapitalizationN/A
Azenta
Price$51.30
Change-$0.27 (-0.52%)
Volume$262.92K
CapitalizationN/A
A vs AZTA Comparison Chart
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. AZTA commentary
Dec 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and AZTA is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 30, 2024
Stock price -- (A: $135.54 vs. AZTA: $51.30)
Brand notoriety: A and AZTA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 34% vs. AZTA: 29%
Market capitalization -- A: $42.66B vs. AZTA: $3.36B
A [@Medical Specialties] is valued at $42.66B. AZTA’s [@Medical Specialties] market capitalization is $3.36B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileAZTA’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • AZTA’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 6 TA indicator(s) are bullish while AZTA’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 6 bullish, 4 bearish.
  • AZTA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both A and AZTA are a good buy in the short-term.

Price Growth

A (@Medical Specialties) experienced а +0.77% price change this week, while AZTA (@Medical Specialties) price change was +1.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.18%. For the same industry, the average monthly price growth was -2.05%, and the average quarterly price growth was +3.00%.

Reported Earning Dates

A is expected to report earnings on Feb 25, 2025.

AZTA is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Medical Specialties (+1.18% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than AZTA($3.36B). A YTD gains are higher at: -2.015 vs. AZTA (-21.247). A has higher annual earnings (EBITDA): 1.69B vs. AZTA (57.5M). AZTA has less debt than A: AZTA (66.5M) vs A (2.56B). A has higher revenues than AZTA: A (6.74B) vs AZTA (641M).
AAZTAA / AZTA
Capitalization42.7B3.36B1,270%
EBITDA1.69B57.5M2,939%
Gain YTD-2.015-21.2479%
P/E Ratio34.82N/A-
Revenue6.74B641M1,051%
Total CashN/A984M-
Total Debt2.56B66.5M3,842%
FUNDAMENTALS RATINGS
A vs AZTA: Fundamental Ratings
A
AZTA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
4183
SMR RATING
1..100
4392
PRICE GROWTH RATING
1..100
5652
P/E GROWTH RATING
1..100
5758
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (21) in the Biotechnology industry is somewhat better than the same rating for AZTA (72) in the Electronic Production Equipment industry. This means that A’s stock grew somewhat faster than AZTA’s over the last 12 months.

A's Profit vs Risk Rating (41) in the Biotechnology industry is somewhat better than the same rating for AZTA (83) in the Electronic Production Equipment industry. This means that A’s stock grew somewhat faster than AZTA’s over the last 12 months.

A's SMR Rating (43) in the Biotechnology industry is somewhat better than the same rating for AZTA (92) in the Electronic Production Equipment industry. This means that A’s stock grew somewhat faster than AZTA’s over the last 12 months.

AZTA's Price Growth Rating (52) in the Electronic Production Equipment industry is in the same range as A (56) in the Biotechnology industry. This means that AZTA’s stock grew similarly to A’s over the last 12 months.

A's P/E Growth Rating (57) in the Biotechnology industry is in the same range as AZTA (58) in the Electronic Production Equipment industry. This means that A’s stock grew similarly to AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAZTA
RSI
ODDS (%)
Bearish Trend 4 days ago
51%
Bearish Trend 4 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
59%
Bullish Trend 4 days ago
68%
MACD
ODDS (%)
Bearish Trend 4 days ago
53%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 7 days ago
61%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
75%
Aroon
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGI1.620.03
+1.89%
Organigram Holdings
VRSN203.951.22
+0.60%
VeriSign
SBRA17.02-0.08
-0.47%
Sabra Health Care REIT
AYTU1.52-0.01
-0.87%
Aytu BioPharma
SHEN12.44-0.57
-4.38%
Shenandoah Telecommunications Co

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with CRL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-0.52%
CRL - AZTA
54%
Loosely correlated
-0.26%
IQV - AZTA
48%
Loosely correlated
-0.43%
BLFS - AZTA
48%
Loosely correlated
-1.63%
RVTY - AZTA
46%
Loosely correlated
-0.45%
A - AZTA
45%
Loosely correlated
-0.21%
More